Intrust Bank’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $683K | Sell |
1,298
-65
| -5% | -$36.5K | 0.05% | 230 |
|
|
2026
Q1 | $766K | Sell |
1,363
-114
| -8% | -$73.1K | 0.06% | 208 |
|
|
2025
Q4 | $999K | Buy |
1,477
+36
| +2% | +$24.5K | 0.08% | 163 |
|
|
2025
Q3 | $921K | Sell |
1,441
-51
| -3% | -$31K | 0.08% | 177 |
|
|
2025
Q2 | $800K | Sell |
1,492
-6
| -0.4% | -$2.87K | 0.07% | 188 |
|
|
2025
Q1 | $629K | Sell |
1,498
-56
| -4% | -$24.3K | 0.06% | 204 |
|
|
2024
Q4 | $642K | Sell |
1,554
-2
| -0.1% | -$877 | 0.07% | 206 |
|
|
2024
Q3 | $786K | Sell |
1,556
-11
| -0.7% | -$5.34K | 0.08% | 186 |
|
|
2024
Q2 | $763K | Sell |
1,567
-48
| -3% | -$24.1K | 0.08% | 181 |
|
|
2024
Q1 | $872K | Sell |
1,615
-121
| -7% | -$66.1K | 0.09% | 172 |
|
|
2023
Q4 | $964K | Sell |
1,736
-38
| -2% | -$17.8K | 0.11% | 151 |
|
|
2023
Q3 | $776K | Sell |
1,774
-115
| -6% | -$57.3K | 0.1% | 165 |
|
|
2023
Q2 | $949K | Hold |
1,889
| – | – | 0.12% | 156 |
|
|
2023
Q1 | $945K | Sell |
1,889
-7
| -0.4% | -$3.35K | 0.12% | 149 |
|
|
2022
Q4 | $773K | Sell |
1,896
-42
| -2% | -$16.3K | 0.11% | 164 |
|
|
2022
Q3 | $632K | Sell |
1,938
-67
| -3% | -$24.6K | 0.1% | 180 |
|
|
2022
Q2 | $704K | Sell |
2,005
-247
| -11% | -$101K | 0.1% | 176 |
|
|
2022
Q1 | $1.23M | Sell |
2,252
-39
| -2% | -$20.5K | 0.16% | 118 |
|
|
2021
Q4 | $1.51M | Sell |
2,291
-170
| -7% | -$107K | 0.18% | 101 |
|
|
2021
Q3 | $1.53M | Sell |
2,461
-27
| -1% | -$18.1K | 0.2% | 95 |
|
|
2021
Q2 | $1.57M | Sell |
2,488
-19
| -0.8% | -$10.5K | 0.21% | 95 |
|
|
2021
Q1 | $1.23M | Hold |
2,507
| – | – | 0.18% | 113 |
|
|
2020
Q4 | $1.25M | Sell |
2,507
-33
| -1% | -$14.8K | 0.19% | 105 |
|
|
2020
Q3 | $999K | Sell |
2,540
-34
| -1% | -$12.6K | 0.18% | 112 |
|
|
2020
Q2 | $850K | Sell |
2,574
-513
| -17% | -$149K | 0.17% | 125 |
|
|
2020
Q1 | $748K | Sell |
3,087
-9
| -0.3% | -$2.35K | 0.21% | 114 |
|
|
2019
Q4 | $808K | Sell |
3,096
-62
| -2% | -$16.3K | 0.18% | 136 |
|
|
2019
Q3 | $859K | Sell |
3,158
-90
| -3% | -$25K | 0.22% | 116 |
|
|
2019
Q2 | $895K | Sell |
3,248
-805
| -20% | -$198K | 0.22% | 114 |
|
|
2019
Q1 | $906K | Hold |
4,053
| – | – | 0.23% | 107 |
|
|
2018
Q4 | $754K | Sell |
4,053
-593
| -13% | -$122K | 0.22% | 118 |
|
|
2018
Q3 | $1.16M | Sell |
4,646
-57
| -1% | -$13.8K | 0.29% | 74 |
|
|
2018
Q2 | $1.02M | Sell |
4,703
-14
| -0.3% | -$2.88K | 0.28% | 81 |
|
|
2018
Q1 | $903K | Sell |
4,717
-65
| -1% | -$12K | 0.26% | 96 |
|
|
2017
Q4 | $747K | Sell |
4,782
-89
| -2% | -$14K | 0.22% | 126 |
|
|
2017
Q3 | $757K | Sell |
4,871
-125
| -3% | -$19.8K | 0.25% | 119 |
|
|
2017
Q2 | $807K | Sell |
4,996
-47
| -0.9% | -$7.63K | 0.28% | 97 |
|
|
2017
Q1 | $779K | Sell |
5,043
-214
| -4% | -$29.5K | 0.28% | 99 |
|
|
2016
Q4 | $617K | Sell |
5,257
-175
| -3% | -$20K | 0.23% | 129 |
|
|
2016
Q3 | $612K | Sell |
5,432
-2,702
| -33% | -$285K | 0.24% | 129 |
|
|
2016
Q2 | $756K | Sell |
8,134
-65
| -0.8% | -$5.58K | 0.31% | 106 |
|
|
2016
Q1 | $642K | Buy |
8,199
+1,974
| +32% | +$142K | 0.23% | 138 |
|
|
2015
Q4 | $454K | Sell |
6,225
-6
| -0.1% | -$428 | 0.17% | 162 |
|
|
2015
Q3 | $463K | Buy |
6,231
+1,461
| +31% | +$105K | 0.18% | 158 |
|
|
2015
Q2 | $306K | Buy |
4,770
+854
| +22% | +$59.1K | 0.11% | 216 |
|
|
2015
Q1 | $302K | Buy |
+3,916
| New | +$305K | 0.11% | 214 |
|
Other funds holding IDXX
Intrust Bank's IDXX Position: Q2 2026 in Review
Intrust Bank reduced its Idexx Laboratories (IDXX) stake by 4.8% in Q2 2026, selling an estimated $36.5K and leaving 1,298 shares worth $683K. The position accounts for 0.05% of the portfolio, ranked #230.
Intrust Bank first reported a position in IDXX in Q1 2015 and has held it in 46 quarters since. The position peaked at $1.57M in Q2 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Intrust Bank held 1,298 shares of Idexx Laboratories worth $683K as of Q2 2026.
- Intrust Bank sold 65 Idexx Laboratories shares in Q2 2026, an estimated $36.5K.
- Idexx Laboratories made up 0.05% of Intrust Bank's portfolio in Q2 2026, its #230 holding.
- Intrust Bank first reported a position in Idexx Laboratories in Q1 2015 and has held it in 46 quarters since.
- Intrust Bank's Idexx Laboratories position peaked at $1.57M in Q2 2021.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.